• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, S.A. VIDAS® FT4 ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, S.A. VIDAS® FT4 ASSAY Back to Search Results
Catalog Number 30459
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem Misdiagnosis (2159)
Event Date 12/09/2016
Event Type  Injury  
Event Description
A customer in (b)(6) notified biomérieux of discrepant results associated with vidas ft4 assay (reference 30459).On (b)(6) 2016 a high result (51.09 pmol/l) was obtained and the test was repeated on the next day ((b)(6) 2016) with a result of 49.51 pmol/l.The result 49.51 pmol/l was communicated to the patient.On (b)(6) 2016 the patient returned for a repeat test.The test result 45.81 pmol/l and was reported to the patient.The patient underwent endocrinology examination, ultrasound scans, and analysis in other areas to exclude any disease, but all results came back normal.The patient went to another lab and the ft4 result was normal.The patient returned to the customer's site on (b)(6) 2016 to repeat the vidas ft4 test (lot 1004988060) and the result was 45.10 pmol/l.The patient returned to the customer's site on (b)(6) 2017 for a repeat test and the result was 43.10 pmol/l.An alternative test electrochemiluminescence method was also performed and the result was 15.79 pg/ml (normal result) culture submittals have been requested by biomérieux for internal investigation.An internal biomérieux investigation has been initiated.
 
Manufacturer Narrative
This report was initially submitted following notification that a customer in italy experienced discrepant vidas® ft4 results as compared to an alternate method (cobas).Biomérieux investigation was conducted.Analysis of the batch history records shows no anomaly during the control process for vidas® ft4 lot 1004988060.Review of complaint history identified no other complaints registered for the referenced lot for the described issue.Testing was performed using the customer lot and a random lot of vidas® ft4; the sample tested was submitted by the customer.The investigational testing obtained overestimated results similar to the customer's results.Several interference tests were performed on the sample submitted by the customer; no origin of interference was identified (heterophilic antibodies or rheumatoid factors).The vidas® ft4 package insert indicates "assay results should be interpreted as part of a complete clinical evaluation and thyroid function assessment, including at least tsh determination." the investigation concluded the overestimated values may be the result of drug interference or cross-reaction with another substance, and is directly related to the patient sample.The vidas® ft4 package insert also indicates "interference may be encountered with certain sera containing antibodies directed against the reagent components.For this reason, assay results should be interpreted taking into consideration the patient's history and the results of any other tests performed." the vidas® ft4 lot 1004988060 assay is performing as expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® FT4 ASSAY
Type of Device
VIDAS® FT4 ASSAY
Manufacturer (Section D)
BIOMERIEUX, S.A.
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX, S.A.
chemin de l orme
marcy l etoile, rhone 69280
FR   69280
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key6323117
MDR Text Key67148661
Report Number3002769706-2017-00024
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K132058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/15/2017
Device Catalogue Number30459
Device Lot Number1004988060
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-